Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
about
Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous SystemImmune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune reEarly emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice.Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production.Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice.TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.Serum corticosterone, interleukin-1 and tumour necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar strainsTNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.Expression of recombinant feline tumor necrosis factor is toxic to Escherichia coli.IL-2 and antigen dose differentially regulate perforin- and FasL-mediated cytolytic activity in antigen specific CD4+ T cells.Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.Spred2 Deficiency Exacerbates D-Galactosamine/Lipopolysaccharide -induced Acute Liver Injury in Mice via Increased Production of TNFα.
P2860
Q27486917-0BC3D37E-1487-4ECE-ADC2-42CE6ECED8EAQ28594116-3B5D6109-F968-4643-999F-DB40508EBCCBQ34001403-1584F065-801A-4564-92E1-C5CDAC3395C6Q34185457-6042D321-3397-4F4E-A226-990342B118FBQ34229344-07BD4AED-0844-4FC3-82A4-480CE2F1233BQ35468420-2911BA20-98D8-4A0E-A414-F111129E8F32Q36121743-6339497B-6014-49B8-AB6C-01B98B20D90CQ36330162-209087E9-B81D-4641-9D49-0B407BE3FC53Q37120229-430D3849-C8D4-4983-B14E-12AC8C1B2ACAQ39810018-B65DF909-191A-41A9-934B-BF22980B9D84Q43125547-C087205E-C33D-404A-8CDC-07EA8EC3A82BQ47139765-AEE87ACF-C4FF-4CC3-B051-99778F26FCFDQ47215637-F3EED2C7-F155-436F-B293-D023A1B52DA0
P2860
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@en
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@nl
type
label
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@en
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@nl
prefLabel
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@en
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@nl
P2093
P1476
Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo.
@en
P2093
P304
P407
P577
1992-06-01T00:00:00Z